BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 574929)

  • 1. [The epicutaneous DNCB test and CEA determination in neoplasms of the breast, digestive tract, lung and urogenital system].
    Bianucci P; Pastorino G; De Rossi O; Brondi P
    Minerva Med; 1979 Dec; 70(54):3701-4. PubMed ID: 574929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The DNCB skin test and its comparison with the radioimmunological determination of CEA in some types of neoplasms].
    Bianucci P; Pastorino G; De Rossi O
    Minerva Med; 1979 May; 70(25):1795-801. PubMed ID: 572515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of the DNCB skin test and CEA assay in the prognosis of malignant neoplasms].
    Ciambellotti E; Moro G
    Arch Sci Med (Torino); 1983; 140(3):267-72. PubMed ID: 6675584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen in effusions. A diagnostic adjunct to cytology.
    Pinto MM; Bernstein LH; Brogan DA; Criscuolo EM
    Acta Cytol; 1987; 31(2):113-8. PubMed ID: 3548190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative DNCB skin test in cancer patients.
    Dutta TK; Sengputa U; Gupta BD
    Indian J Cancer; 1977 Dec; 14(4):351-3. PubMed ID: 612559
    [No Abstract]   [Full Text] [Related]  

  • 6. DNCB and PPD skin testing in breast cancer.
    Munzarová M; Kovarík J; Ninger E; Zemanová D; Lauerová L; Kolcová V; Hlávková J; Pacovský Z
    Neoplasma; 1983; 30(4):385-9. PubMed ID: 6888607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "DNCB reactivity in cancer patients and during follow-up period".
    Hardas UD; Jalgaonkar SV
    Indian J Cancer; 1982; 19(5):260-2. PubMed ID: 7166344
    [No Abstract]   [Full Text] [Related]  

  • 8. [The DNCB test in pneumology].
    Polistina D
    Arch Monaldi; 1977; 32(3):15-8. PubMed ID: 616268
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior of DNCB and tuberculin skin tests in relation to the various histological types of pulmonary cancer].
    Soresi V; Invernizzi G; Schiraldi G; Borghini U; Sacerdoti C; Maruzzi M
    Boll Ist Sieroter Milan; 1981 Jul; 60(3):216-21. PubMed ID: 6275868
    [No Abstract]   [Full Text] [Related]  

  • 10. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up.
    Munzarová M; Kovarík J; Hlávková J; Popelínský L; Lauerová L
    Neoplasma; 1985; 32(1):45-50. PubMed ID: 3982560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis.
    Inoue H; Ishihara T; Kobayashi K; Fukai S
    J Thorac Cardiovasc Surg; 1978 Oct; 76(4):479-82. PubMed ID: 703354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value and significance of CEA in the monitoring of patients with neoplasms and in the evaluation of their cure].
    Mauri S; Tagliabue P; Margara C; Bellan L
    Minerva Med; 1982 Mar; 73(11):589-92. PubMed ID: 7063126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)].
    Di Martino G; Iannucci F; Bizzarro A; Iacono G
    Boll Ist Sieroter Milan; 1982; 61(5):411-22. PubMed ID: 6985416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The carcinoembryonic antigen test in urologic cancer.
    Guinan PD; McKiel C; Sundar B; Veith R; Dubin A; Ablin RJ
    Natl Cancer Inst Monogr; 1978 Dec; (49):225-9. PubMed ID: 748773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of carcinoembryonic antigen (CEA) and CEA-S assays in the evaluation of neoplasm of the gastrointestinal tract.
    Nakamura RM; Plow EF; Edgington TS
    Ann Clin Lab Sci; 1978; 8(1):4-10. PubMed ID: 623429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dinitrochlorobenzene contact sensitization in patients with end-stage renal disease.
    Waltzer WC; Gonder MJ
    Allergol Immunopathol (Madr); 1984; 12(6):479-82. PubMed ID: 6335629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Delayed skin hypersensitivity to 2,4-dinitrochlorobenzene (DNCB) in patients with bronchial carcinoma].
    Ruszel KB
    Wiad Lek; 1978 Oct; 31(19):1341-4. PubMed ID: 716404
    [No Abstract]   [Full Text] [Related]  

  • 19. [Delayed hypersensitivity intracutaneous test with dinitrochlorobenzene (DNCB)].
    Grigorovich NA; Martysiuk TI; Monastyrnaia PL
    Vopr Onkol; 1979; 25(7):94-5. PubMed ID: 483690
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Relationship between the DNCB test and prognosis in cancer patients.
    Dubois JB; Serrou B
    Br J Surg; 1974 Apr; 61(4):326. PubMed ID: 4832661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.